Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid

被引:6
|
作者
Dogan, Ismail [1 ]
Kalyoncu, Umut [2 ]
Kilic, Levent [2 ]
Akdogan, Ali [2 ]
Karadag, Omer [2 ]
Kiraz, Sedat [2 ]
Bilgen, Sule A. [2 ]
Ertenli, Ihsan [2 ]
机构
[1] Yildirim Beyazit Univ, Dept Internal Med, Div Rheumatol, Ankara, Turkey
[2] Hacettepe Univ, Dept Internal Med, Div Rheumatol, Ankara, Turkey
关键词
Avascular necrosis; alternate day steroid usage; systemic lupus erythematosus; FEMORAL-HEAD; IDIOPATHIC OSTEONECROSIS; DISEASE-ACTIVITY; BONE NECROSIS; RISK-FACTORS; SLE; CLASSIFICATION; PREVALENCE; CRITERIA; THERAPY;
D O I
10.3906/sag-1908-182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. Materials and methods: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. Results: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. Conclusion: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 50 条
  • [31] ANALYSIS OF RISK FACTORS AND ASSESSMENT OF THE COURSE OF AVASCULAR NECROSIS OF THE FEMORAL HEAD IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Kovalenko, V. M.
    Protsenko, H. O.
    Dubas, V. V.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 83 (01): : 91 - 95
  • [32] Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus
    Zangger, P
    Gladman, DD
    Urowitz, MB
    Bogoch, ER
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (04) : 919 - 923
  • [33] AVASCULAR NECROSIS OF BONE AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ASHERSON, RA
    LIOTE, F
    PAGE, B
    MEYER, O
    BUCHANAN, N
    KHAMASHTA, MA
    JUNGERS, P
    HUGHES, GRV
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (02) : 284 - 288
  • [34] Long-term observation of avascular necrosis of the femoral head in systemic lupus erythematosus: An MRI study
    Yoshida, T
    Kanayama, Y
    Okamura, M
    Negoro, N
    Inoue, T
    Yoshikawa, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (04) : 525 - 530
  • [35] Corticosteroid use in childhood-onset systemic lupus erythematosus - practice patterns at four pediatric rheumatology centers
    Brunner, H. I.
    Klein-Gitelman, M. S.
    Ying, J.
    Tucker, L. B.
    Silverman, E. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : 155 - 162
  • [36] HIP JOINT AVASCULAR NECROSIS IN A MULTI-ETHNIC SYSTEMIC LUPUS ERYTHEMATOSUS COHORT
    Shaharir, S. S.
    Mohd, R.
    Mustafar, R.
    Shahril, N. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 316 - 316
  • [37] Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel
    Petri, M.
    Bechtel, B.
    Dennis, G.
    Shah, M.
    McLaughlin, T.
    Kan, H.
    Molta, C.
    LUPUS, 2014, 23 (10) : 1006 - 1013
  • [38] Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus
    Shah, Manan
    Chaudhari, Sham
    McLaughlin, Trent P.
    Kan, Hong J.
    Bechtel, Benno
    Dennis, Gregory J.
    Molta, Charles T.
    CLINICAL THERAPEUTICS, 2013, 35 (04) : 486 - 497
  • [39] Cortisol During the Day in Patients with Systemic Lupus Erythematosus or Primary Sjogren's Syndrome
    van der Goes, Marlies C.
    Bossema, Ercolie R.
    Hartkamp, Andre
    Godaert, Guido L. R.
    Jacobs, Johannes W. G.
    Kruize, Aike A.
    Derksen, Ronald H. W. M.
    Bijlsma, Johannes W. J.
    Geenen, Rinie
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (02) : 285 - 288
  • [40] Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study
    Abe, Kazuya
    Ishikawa, Yuichi
    Kita, Yasuhiko
    Yajima, Nobuyuki
    Inoue, Eisuke
    Sada, Ken-Ei
    Miyawaki, Yoshia
    Yoshimi, Ryusuke
    Shimojima, Yasuhiro
    Ohno, Shigeru
    Kajiyama, Hiroshi
    Ichinose, Kunihiro
    Sato, Shuzo
    Fujiwara, Michio
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)